NCT06382285

Brief Summary

The aim of this study is to examine the effect of a prolonged peripheral nerve block (utilizing continuous adductor canal block) on the level of pain after a knee replacement surgery

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2023

Completed
8 months until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

October 30, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

September 7, 2023

Last Update Submit

April 21, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain level

    Documentation of pain level during the hospitalization days every 12 hours (on a scale of 1-10)

    during hospitalization (1-2 days)

  • Analgesic use

    Documentation of pain level during the hospitalization days every 12 hours (on a scale of 1-10). Documentation of analgesic administration in hospitalization.

    during hospitalization (1-2 days)

Secondary Outcomes (1)

  • Physiotherapy

    during hospitalization (1-2 days)

Study Arms (2)

Treatment group

EXPERIMENTAL

ropivacaine (Naropin) 0.2% according to a protocol 8-10 cc per hour up to 24 hours after the surgery

Drug: Continues peripheral block

Control group

PLACEBO COMPARATOR

Saline according to a protocol 8-10 cc per hour up to 24 hours after the surgery

Drug: Continues peripheral block

Interventions

ropivacaine (Naropin) 0.2% according to a protocol 8-10 cc per hour up to 24 hours after surgery

Also known as: Treatment group
Control groupTreatment group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female and male patients between the ages of 18 and 80 who have signed an informed consent form.
  • ASA is less than 3
  • Spinal anesthesia

You may not qualify if:

  • Patients with sensitivity to the anesthetic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Sara Bar Yehuda, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study will include 50 patients who underwent a knee replacement surgery, who will be randomized to 2 groups. 6 hours after surgery the two groups will be connected to a prolonged block pump. One group will receive the peripheral block ropivacaine 0.2% according to the protocol of 8-10 cc per hour up to 24 hours after surgery. The second group will receive saline according to the same protocol
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the anesthesia department

Study Record Dates

First Submitted

September 7, 2023

First Posted

April 24, 2024

Study Start

October 30, 2024

Primary Completion

October 30, 2025

Study Completion

January 31, 2026

Last Updated

April 24, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share